| The evolution of genetic science promises the | | | | simplified with help of patent filter model. |
| power to transform humanity. While the | | | | Patent Application in gene invention is done in |
| geneticists offer to cure the world of all its | | | | most countries of the world including USA, India, |
| problems, the commons view the field with | | | | Europe, Canada, China, Korea, Germany, Holland, |
| caution because of its interface with life. Though | | | | Britain, Australia, Japan, Genetic patent application |
| the benefits offered by the field seem to be | | | | can be for gene patent, patent ductus arteriosis, |
| unlimited, genetics as field is nascent and uncertain. | | | | patent ductus arteriosus, biotech patent, |
| The ambiguities inherent in the field pose | | | | biotechnology patent, gene patenting, patent |
| challenges for application of the traditional patent | | | | foramen ovale, patent medicine. |
| principles to genetic inventions. | | | | The Patent regime is believed to promote the |
| Due to variations in social, economic and ideological | | | | progress of science and technology by providing |
| conditions the patent law relating to genetic | | | | incentives to inventors and inventors in the form |
| inventions is treated differently in different | | | | of exclusive rights. Through these incentives, the |
| countries. Concepts under the patent law relating | | | | patent system encourages investment for R&D, |
| to gene-bases inventions like what is and what | | | | expands the limit of a discipline, fosters invention |
| should be patentable, which inventions are useful, | | | | and mandates disclosure. As the incentives form |
| what should e the standard of novelty and | | | | the foundation for operation of the patent |
| non-obviousness, how should be imposed on the | | | | system, a granted patent would be an indication |
| use of patented inventions in the name of morals, | | | | of R&D, inventive activity, and technology |
| ethics and public policy have been expounded by | | | | progress. Furthermore, as patents grant exclusive |
| laws of different countries in a diverse manner. | | | | rights to exploit the inventions commercially for a |
| The ambiguity and diversity inherent in the | | | | limited period of time, they represent indicators of |
| application of patent law to genetic inventions | | | | business activity. |
| makes the analysis of patentability and related | | | | Patents have been recognized to be a source of |
| business advantage complex. The complexity can | | | | empirical data to understand and analyse inventive |
| be alleviated by studying the patentability of | | | | activity/innovation, trends and specifies in |
| genetic inventions in USA, Euorope and India from | | | | technology of development, R&D processes, |
| a comparative perspective with the help of case | | | | technological change and innovation and |
| studies and examples. The process of analyzing | | | | investment patterns. |
| patentabliity and their impact on business can be | | | | |